Skip to main content
TipRanks
Go Ultimate75% OFF

TWi Biotechnology, Inc (6610) Financial Statements

TWi Biotechnology, Inc Financial Overview

TWi Biotechnology, Inc's market cap is currently NT$3.92B. The company's EPS TTM is NT$-1.46; its P/E ratio is -12.05; TWi Biotechnology, Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00NT$ 66.40M
Gross ProfitNT$ -35.32MNT$ -9.70MNT$ -9.74MNT$ -10.35MNT$ 65.48M
Operating IncomeNT$ -357.02MNT$ -178.49MNT$ -169.56MNT$ -90.18MNT$ -15.30M
EBITDANT$ -321.70MNT$ -154.94MNT$ -160.86MNT$ -65.78MNT$ -4.11M
Net IncomeNT$ -202.37MNT$ -164.81MNT$ -170.68MNT$ -76.18MNT$ -15.30M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 263.72MNT$ 175.60MNT$ 323.69MNT$ 160.40MNT$ 223.14M
Total AssetsNT$ 723.58MNT$ 242.32MNT$ 396.85MNT$ 234.31MNT$ 311.04M
Total DebtNT$ 2.95MNT$ 15.60MNT$ 7.97MNT$ 2.53MNT$ 5.02M
Net DebtNT$ -260.77MNT$ -111.19MNT$ -143.86MNT$ -157.87MNT$ -183.81M
Total LiabilitiesNT$ 93.14MNT$ 66.47MNT$ 55.81MNT$ 28.39MNT$ 32.24M
Stockholders' EquityNT$ 630.44MNT$ 175.85MNT$ 341.04MNT$ 205.92MNT$ 278.80M
Cash Flow
Free Cash FlowNT$ -287.40MNT$ -155.72MNT$ -134.22MNT$ -60.24MNT$ -64.69M
Operating Cash FlowNT$ -286.99MNT$ -155.41MNT$ -134.22MNT$ -60.24MNT$ -34.46M
Investing Cash FlowNT$ 42.90MNT$ 122.75MNT$ -171.85MNT$ 34.30MNT$ 161.64M
Financing Cash FlowNT$ 167.34MNT$ 7.63MNT$ 297.50MNT$ -2.50MNT$ -2.46M

Currency in TWD

TWi Biotechnology, Inc Earnings and Revenue History

-240M-120M0120M-9000 %-6000 %-3000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

TWi Biotechnology, Inc Liabilities to Assets

0300M600M900M0 %10 %20 %30 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

TWi Biotechnology, Inc Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing

TWi Biotechnology, Inc Forecast EPS vs Actual EPS